Joseph W. Boggs, PhD

Chief Scientific Officer & Senior Vice President, Research and Development
SPR
Cleveland, Ohio, United States

Presentation(s):

• Survey shows durable relief with Percutaneous 60-Day PNS used to treat knee pain in patients seeking non-surgical management

  Thursday, November 13, 2025
  11:12 AM - 11:20 AM CT

  Disclosure information not submitted.

• Percutaneous 60-Day PNS to treat chronic knee pain: Results from a multi-center, retrospective chart review

  Friday, November 14, 2025
  9:20 AM - 9:28 AM CT

  Disclosure information not submitted.

• Long-term efficacy of Percutaneous 60-Day Peripheral Nerve Stimulation out to five years: A cross-sectional follow-up survey

  Friday, November 14, 2025
  11:34 AM - 11:42 AM CT

  Disclosure information not submitted.

• Durable Outcomes of Percutaneous 60-Day Peripheral Nerve Stimulation for Low Back Pain: A 5-Year Cross-Sectional Follow-Up Survey

  Friday, November 14, 2025
  10:30 AM - 10:35 AM CT

  Disclosure information not submitted.

• Percutaneous 60-Day PNS relieves postoperative pain and pain interference after total knee arthroplasty 12 months after treatment

  Friday, November 14, 2025
  1:50 PM - 1:55 PM CT

  Disclosure information not submitted.

• 60-Day PNS vs. Standard Interventional Management for Chronic Low Back Pain: RESET RCT 6-Month Results

  Friday, November 14, 2025
  4:15 PM - 4:20 PM CT

  Disclosure information not submitted.